EMEA-001568-PIP03-14
Key facts
| Active substance |
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0054/2015
|
| PIP number |
EMEA-001568-PIP03-14
|
| Pharmaceutical form(s) |
Powder for solution for injection or infusion
|
| Condition(s) / indication(s) |
Treatment of bacterial infections
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Venus Pharma GmbH
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|